Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2025-12-26 @ 11:41 PM
Study NCT ID:
NCT01004250
Status:
COMPLETED
Last Update Posted:
2014-05-21
First Post:
2009-10-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-10
Start Date Type:
None
Primary Completion Date:
2012-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-12
Completion Date Type:
ACTUAL
First Submit Date:
2009-10-28
First Submit QC Date:
None
Study First Post Date:
2009-10-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-11-07
Results First Submit QC Date:
None
Results First Post Date:
2013-12-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-04-23
Last Update Post Date:
2014-05-21
Last Update Post Date Type:
ESTIMATED